Correlations between the four clinical subtypes and the three morphologic variants (P = .0003)
| . | n . | Splenic Subtype . | Leukemic Subtype . | Nodal Subtype . | Disseminated Subtype . |
|---|---|---|---|---|---|
| No. patients | 124 | 59 | 8 | 37 | 20 |
| SLVL | 12 | 11 (19%) | — | — | 1 (5%) |
| Common | 78 | 38 (64%) | 8 (100%) | 18 (49%) | 14 (70%) |
| Large cell-rich variant | 34 | 10 (17%) | — | 19 (51%) | 5 (25%) |
| . | n . | Splenic Subtype . | Leukemic Subtype . | Nodal Subtype . | Disseminated Subtype . |
|---|---|---|---|---|---|
| No. patients | 124 | 59 | 8 | 37 | 20 |
| SLVL | 12 | 11 (19%) | — | — | 1 (5%) |
| Common | 78 | 38 (64%) | 8 (100%) | 18 (49%) | 14 (70%) |
| Large cell-rich variant | 34 | 10 (17%) | — | 19 (51%) | 5 (25%) |
SLVL = splenic lymphoma with villous lymphocyte.